Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.
about
Metaraminol (Aramine) in the management of a significant amlodipine overdose.Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failureInotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiologyDose-dependent effect of dobutamine on chemoreflex activity in healthy volunteers.Use of inotropes and vasopressor agents in critically ill patients.The utility of levosimendan in the treatment of heart failure.Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials.Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 1, drugs administered intravenously).Pharmacogenetics of cardiac inotropy.Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial diseaseApart from the other members of PDE inhibitors' family, enoximone does not enhance renal ischemic reperfusion injury: the effects of enoximone on renal ischemia reperfusion.Preoperative inhalation of milrinone attenuates inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass.Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation.Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity.Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in gynecologic patients.Milrinone, a phosphodiesterase III inhibitor, prevents reduction of jugular bulb saturation during rewarming from hypothermic cardiopulmonary bypass.The Perspective of the Intensivist on Inotropes and Postoperative Care Following Pediatric Heart Surgery: An International Survey and Systematic Review of the Literature.Experiences of levosimendan as an inotropic agent in conjunction with passive containment surgery.
P2860
Q34445262-FB8223C7-A81B-4036-826E-2E24B44C5F17Q34999274-34D61602-009E-4007-86A2-88CDE993A81AQ35077700-00D47447-2833-40D7-8ACE-183923CC6CC9Q35827747-EF8893DD-3F52-47BA-8AD8-C6DB386C527BQ36147248-7F240654-AE8C-485E-BE7B-60E627E926B7Q36761355-944D0835-EF74-4383-A47F-F82614331231Q37967364-2898E7DD-E171-4271-A772-BDE70AB2EDB7Q38076347-271F8C89-EE7F-4EEA-A041-110018E062A2Q38286038-8831484F-FCF7-4AB2-916B-28E366695E36Q41476461-3ED7A3CE-EAAD-45CC-9766-01BB2651B0F7Q43210204-076AE176-DBFB-462B-A1EA-6ED13A0FB6ACQ44702842-F7774F97-396B-497B-AB65-F644126FAB7EQ45368304-F0582DA8-2FA2-4AD2-BC8C-CF40834285A0Q46958518-F3B1AFAE-875C-4947-AD3D-B794514FEF80Q47820549-A882B975-2585-4819-B121-699A4C55F491Q48225161-3658366A-361D-43EA-B7B7-3F1D3D79325FQ48380637-E2EF7FD9-7E92-49D4-BF9C-84B62D06FCF1Q48599338-2AC04EBE-F6DF-4E90-BA7A-2BCF4ABF96A8
P2860
Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.
@ast
Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.
@en
type
label
Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.
@ast
Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.
@en
prefLabel
Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.
@ast
Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.
@en
P2093
P1476
Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.
@en
P2093
Lasse A Lehtonen
Pertti J Pentikäinen
Saila Antila
P304
P356
10.2165/00003088-200443030-00003
P577
2004-01-01T00:00:00Z
P5875
P6179
1031914822